Table 1.

Demographic data and mean fecal calprotectin concentrations of the different study groups (mean ± SD)

Groups	n	Sex (M/F)	Age (yr)	FCCs (μg/g)
Patients	61	28/33	49.64 ± 13.80	28.25 ± 23.43
Active gastritis	35	15/20	49.66 ± 14.15	29.70 ± 21.26
Mild	15	6/9	48.07 ± 14.56	31.44 ± 22.55
Moderate	10	7/3	47.60 ± 13.72	31.08 ± 23.68
Marked	10	2/8	53.30 ± 14.64	26.57 ± 17.66
Non active gastritis	26	13/13	49.90 ± 13.61	25.97 ± 22.55
Healthy controls	74	32/42	45.93 ± 12.42	31.20 ± 19.18

FCCs: Fecal calprotectin concentrations.